Munger Mode rating: 2 out of 5 — Sell. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Reference price: about $77 per share. The stock closed near $76.92 after the Q3 report on October 28, 2026, and I could not confirm a later close. We rely on the 10-Q for the quarter ended September 30, 2026, the company's Q3 earnings release, and a handful of news summaries of the call and guidance. We did not look at any other investor's holdings. Where a number comes from outside the 10-Q, we say so. GE HealthCare makes the machines hospitals use to look inside patients (CT, MRI, X-ray, ultrasound, molecular imaging), the contrast and radioactive agents injected for those scans, and the monitors that sit at the bedside. It then services all of it for a decade or more. It is a good business, but not a wonderful one. The quarter was good. Revenue grew 7% to $5.51 billion and operating income rose 23% to $805 million.
Recent filings analysed: 8-K (2026-11-05), 10-Q (2026-10-28), 8-K (2026-10-28), 8-K (2026-09-22).
Stock screener · Superinvestor 13F holdings · Analyst sentiment